MR
Michael Ryskin B of A Securities Latest Price Targets & Analyst Ratings
| Stock | Price | Price Target |
Upside Downside | Rating | Date | |
|---|---|---|---|---|---|---|
|
TEM
1
Tempus AI, Inc. Class A Common Stock
TEM
$14.1B
| $81.01 | $70 |
14%
downside
| Neutral |
25 Jun ‘25
2 months ago |
|
2
Idexx Laboratories
IDXX
$52.2B
| $655.60 | $475 |
28%
downside
| Neutral |
21 Apr ‘25
4 months ago |
|
3
Maravai LifeSciences
MRVI
$353M
| $2.66 | $8 |
201%
upside
| Buy |
3 Mar ‘25
6 months ago |
|
4
Align Technology
ALGN
$9.85B
| $135.93 | $206 |
52%
upside
| Underperform |
13 Dec ‘24
9 months ago |
|
5
Guardant Health
GH
$7.41B
| $59.44 | $40 |
33%
downside
| Buy |
18 Jul ‘24
1 year ago |
|
6
Alight
ALIT
$1.96B
| $3.71 | $9.50 |
156%
upside
| Buy |
25 Jun ‘24
1 year ago |
|
7
Certara
CERT
$1.72B
| $10.96 | $24 |
119%
upside
| Buy |
15 Aug ‘23
2 years ago |
|
8
Avantor
AVTR
$8.75B
| $12.83 | $24 |
87%
upside
| Buy |
31 Jul ‘23
2 years ago |
|
9
Zoetis
ZTS
$67.3B
| $149.79 | $180 |
20%
upside
| Buy |
4 Nov ‘22
2 years ago |
|
10
Schrodinger
SDGR
$1.43B
| $19.46 | $52 |
167%
upside
| Neutral |
11 Nov ‘21
3 years ago |
|
11
Absci
ABSI
$380M
| $2.54 | $10 |
294%
upside
| Underperform |
10 Nov ‘21
3 years ago |
|